Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$657.71 - $825.77 $1.19 Million - $1.5 Million
-1,812 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$576.64 - $649.04 $1.61 Million - $1.81 Million
-2,786 Reduced 60.59%
1,812 $1.17 Million
Q1 2021

May 06, 2021

BUY
$547.01 - $662.35 $725,882 - $878,938
1,327 Added 40.57%
4,598 $2.63 Million
Q4 2020

Feb 09, 2021

BUY
$510.68 - $643.45 $390,159 - $491,595
764 Added 30.47%
3,271 $1.91 Million
Q3 2020

Nov 09, 2020

BUY
$454.43 - $535.6 $76,344 - $89,980
168 Added 7.18%
2,507 $1.29 Million
Q2 2020

Aug 04, 2020

BUY
$334.87 - $493.06 $527,085 - $776,076
1,574 Added 205.75%
2,339 $1.06 Million
Q1 2020

May 06, 2020

BUY
$320.01 - $409.07 $244,807 - $312,938
765 New
765 $268,000
Q4 2019

Feb 11, 2020

SELL
$319.73 - $374.2 $435,472 - $509,660
-1,362 Closed
0 $0
Q3 2019

Nov 07, 2019

SELL
$304.55 - $345.24 $527,176 - $597,610
-1,731 Reduced 55.97%
1,362 $453,000
Q2 2019

Jul 25, 2019

BUY
$286.93 - $312.59 $616,612 - $671,755
2,149 Added 227.65%
3,093 $967,000
Q1 2019

Apr 15, 2019

SELL
$224.3 - $317.41 $531,366 - $751,944
-2,369 Reduced 71.51%
944 $289,000
Q4 2018

Feb 12, 2019

BUY
$220.1 - $309.0 $205,133 - $287,988
932 Added 39.14%
3,313 $769,000
Q3 2018

Nov 14, 2018

SELL
$289.28 - $326.15 $592,734 - $668,281
-2,049 Reduced 46.25%
2,381 $745,000
Q2 2018

Aug 07, 2018

BUY
$244.1 - $303.88 $20,016 - $24,918
82 Added 1.89%
4,430 $1.28 Million
Q1 2018

May 04, 2018

SELL
$233.97 - $274.11 $55,918 - $65,512
-239 Reduced 5.21%
4,348 $1.09 Million
Q4 2017

Feb 01, 2018

BUY
$216.94 - $271.3 $557,101 - $696,698
2,568 Added 127.19%
4,587 $1.1 Million
Q3 2017

Oct 18, 2017

BUY
$212.27 - $242.28 $428,573 - $489,163
2,019
2,019 $449,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.48B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.